EUVIMEDEUVIMED entdecken
Crossref

Targeting Melatonin to Mitochondria Mitigates Castration‐Resistant Prostate Cancer by Inducing Pyroptosis

Xiaohui Chen, Mairehaba Kadier, Mengting Shi, Kefeng Li, Hongtao Chen, Yongzhen Xia, Qiaohua Wang, Rongna Li, Yili Long, Jingbo Qin, Hao Wang, Guanmin Jiang iD

Small · 2025-06 · 21 (22)

DOI: 10.1002/smll.202408996 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 26.04.2025. Verfasst von Xiaohui Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, 519000, China. Hauptthemen laut MEDLINE: Melatonin, Pyroptosis, Mitochondria, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Scientific Research Project of Anhui Provincial Education Department, Postdoctoral Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer frequently progresses to castration‐resistant prostate cancer (CRPC) following androgen deprivation therapy, presenting a significant clinical challenge. Targeting tumor metabolism, particularly mitochondrial pathways, offers a promising strategy for overcoming CRPC. The modification of melatonin (Mel) to a triphenylphosphonium (TPP) cation‐targeted mitochondria–melatonin (Mito–Mel) significantly increases its potency by over 1000‐fold. Mito–Mel selectively targets mitochondria, enhancing reactive oxygen species (ROS) generation and causing mitochondrial membrane potential disruption. This leads to the inhibition of mitochondrial respiration including the tricarboxylic acid (TCA) cycle and oxidative phosphorylation (OXPHOS), which, in turn, suppresses CRPC survival metabolic adaptations, such as glycolysis. In vitro and in vivo experiments reveal for the first time that natural small molecule compound with mitochondrial targeting via TPP exhibits excellent anticancer efficacy by inducing tumor cellular pyroptosis and facilitating the immune response, underlining the encouraging promise of this strategy for the effective treatment of CRPC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelatoninPyroptosisMitochondriaProstatic Neoplasms, Castration-ResistantMaleHumansAnimalsCell Line, TumorReactive Oxygen SpeciesMiceMembrane Potential, MitochondrialOxidative Phosphorylation

Stichwörter der Autor:innen

castration‐resistant prostate cancerimmune responsemito–melatoninpyroptosistumor metabolism

Substanzen

MelatoninReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Clinical Laboratory, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, 519000, China.
  • Center for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macau SAR, 999078, China.
  • Guangdong Provincial Engineering Research Center of Molecular Imaging and Guangdong-Hong Kong-Macao University Joint Laboratory of Interventional Medicine Foundation of Guangdong Province, The Fifth Affiliated Hospital,…
  • Department of Clinical Laboratory, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China.

ORCID-Profile: Guanmin Jiang

Förderung

  • National Natural Science Foundation of China
  • Scientific Research Project of Anhui Provincial Education Department
  • Postdoctoral Science Foundation of China
  • Postdoctoral Fellowship Program (Grade B) of China Postdoctoral Science Foundation
  • Fundamental and Applied Basic Research Funds of Guangdong Province
  • Fujian Provincial Key Laboratory of Innovative Drug Target Research
  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Chen, X., Kadier, M., Shi, M., Li, K., Chen, H., Xia, Y., Wang, Q., Li, R., Long, Y., Qin, J., Wang, H., & Jiang, G. (2025). Targeting Melatonin to Mitochondria Mitigates Castration‐Resistant Prostate Cancer by Inducing Pyroptosis. Small, 21(22). https://doi.org/10.1002/smll.202408996

Vancouver

Chen X, Kadier M, Shi M, Li K, Chen H, Xia Y, et al. Targeting Melatonin to Mitochondria Mitigates Castration‐Resistant Prostate Cancer by Inducing Pyroptosis. Small. 2025;21(22). doi:10.1002/smll.202408996

BibTeX
@article{Chen2025,
  author = {Chen, Xiaohui and Kadier, Mairehaba and Shi, Mengting and Li, Kefeng and Chen, Hongtao and Xia, Yongzhen and Wang, Qiaohua and Li, Rongna and Long, Yili and Qin, Jingbo and Wang, Hao and Jiang, Guanmin},
  title = {Targeting Melatonin to Mitochondria Mitigates Castration‐Resistant Prostate Cancer by Inducing Pyroptosis},
  journal = {Small},
  year = {2025},
  volume = {21},
  number = {22},
  doi = {10.1002/smll.202408996}
}
Kostenlos starten →